Opioid Dependence Treatment Market Overview

An overview of conceptual frameworks, analytical approaches of the Opioid Dependence Treatment market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Opioid Dependence Treatment market is expected to grow with significant rate in the near future.

The global opioid dependence treatment market in 2020 is estimated for more than US$ 2.3 Bn and expected to reach a value of US$ 5.0 Bn by 2028 with a significant CAGR of 10.1%.

Opioid Dependence Treatment Market Definition

The healthcare industry has gone through a huge evolution over the past decade, hence providing technologically advanced medical devices and improved treatments to the patients in the present-day world. By the same token, opioids are drugs such as morphine, codeine, heroin, methadone, and opium, are also used as medications, majorly in cases of severe post-surgical or chronic pain. Although, it may cause addiction and lead to serious health issues.

Noticeably, opioid withdrawal syndrome is considered a life-threatening medical condition following from opioid dependence. Therefore, opioid dependence treatment is uncertain and dangerous as sometimes it can even result in overdose of medications and loss of life. Hence this opioid dependence requires treatment that is known as opioids withdrawal treatment.

The advancements in the healthcare industry has driven the growth of the global opioid dependence treatment market as Europe records for the second-largest market and holds a healthy share in the global opioid dependence treatment market. Thus, the global opioid dependence treatment market is projected to observe rapid growth in the upcoming years.

Opioid Dependence Treatment Market Dynamics

The continuously rising count of chronic diseases as well as the associated surgeries among the population is majorly fueling the growth of the global opioid dependence treatment market. Basically, opioids are drugs including heroin, morphine and many more used as medications in patients in order to reduce the severe pain post-surgery.

Although drugs used as medications have the uncertainty to cause severe health problems and addiction to the patients, ultimately leading to loss of life. Thus, it required opioids dependence treatment to cure the addiction and health problems caused by the medications.

The huge advancements in the healthcare industry in the present-day world is also acting as a major driver that is expected to propel the growth of the global opioid dependence treatment market in the forthcoming years. In addition to that, the growing healthcare expenditure as well as constantly increasing prevalence of chronic ailments among the population across the world is also expected to give a positive boost to the growth of the global opioid dependence treatment market during the forecast timeframe.

Furthermore, the dynamic life science patterns and rising usage of narcotics in pain management is also a major cause for opioid dependency, which is further projected to elevate the growth of the global opioid dependence treatment market in the coming years.

Opioid Dependence Treatment Market Segmentation

The opioid dependence treatment market is segmented on the basis of drug class, sales channel, and by region.

On the basis of drug class, the opioid dependence treatment market is segmented into

Buprenorphine

Naloxone

Methadone

While on the basis of sales channel the market can be segmented into

Retail Pharmacies

Hospitals

Rehabilitation Centres

On the basis of Region, the opioid dependence treatment market is segmented into

North America (U.S., Canada)

Latin America (Brazil, Mexico, Argentina, Rest of Latin America)

Europe (U.K., Germany, Italy, France, Spain, Russia, Poland, BENELUX, NORDIC)

Asia Pacific (China, India, Japan, Australia and New Zealand, South Korea, ASEAN, Rest of Asia)

Middle East (GCC Countries, Israel, Oman, Rest of Middle East)

Africa (South Africa, Egypt, North Africa, Rest of Africa)

Opioid Dependence Treatment Market Key Players

Some of the key participating players in the opioid dependence treatment market are Reckitt Benckiser Pharmaceuticals Inc., Mylan, Dr. Reddy's Laboratories, ADAPT Pharma, Inc., LUMITOS AG, and Others.

MMC Overview on Opioid Dependence Treatment Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Opioid Dependence Treatment market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. The report is titled as ‘Opioid Dependence Treatment Market: Opportunity Analysis and Future Assessment 2020-2028’.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Opioid Dependence Treatment

•    Advantage of Opioid Dependence Treatment

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Opioid Dependence Treatment Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Opioid Dependence Treatment Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Opioid Dependence Treatment Market Snapshot

2.4.    Global Opioid Dependence Treatment Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Opioid Dependence Treatment Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Opioid Dependence Treatment Market, By Drug Class

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Drug Class

3.1.2.    BPS Analysis, By Drug Class

3.2.    Market Revenue (US$Mn) Forecast, By Drug Class

3.2.1.    Buprenorphine

3.2.2.    Naloxone

3.2.3.    Methadone

3.3.    Global Opioid Dependence Treatment Market Attractiveness Index, By Drug Class

4.    Global Opioid Dependence Treatment Market, By Sales Channel

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Sales Channel

4.1.2.    BPS Analysis, By Sales Channel

4.2.    Market Revenue (US$Mn) Forecast, By Sales Channel

4.2.1.    Retail Pharmacies

4.2.2.    Hospitals

4.2.3.    Rehabilitation Centres

4.3.    Global Opioid Dependence Treatment Market Attractiveness Index, By Sales Channel

5.    Global Opioid Dependence Treatment Market, By Region

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Region

5.1.2.    BPS Analysis, By Region

5.2.    Market Revenue (US$Mn) Forecast, By Region

5.2.1.    North America

5.2.2.    Latin America

5.2.3.    Europe

5.2.4.    Asia Pacific

5.2.5.    Middle East

5.2.6.    Africa

5.3.    Global Opioid Dependence Treatment Market Attractiveness Index, By Region

6.    North America Opioid Dependence Treatment Market Analysis and Forecast, 2020–2028

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market Revenue (US$Mn) Forecast, By Country

6.2.1.    U.S. Opioid Dependence Treatment Market

6.2.2.    Canada Opioid Dependence Treatment Market

6.3.    North America Opioid Dependence Treatment Market, By Drug Class

6.3.1.    Buprenorphine

6.3.2.    Naloxone

6.3.3.    Methadone

6.4.    North America Opioid Dependence Treatment Market, By Sales Channel

6.4.1.    Retail Pharmacies

6.4.2.    Hospitals

6.4.3.    Rehabilitation Centres

6.5.    North America Opioid Dependence Treatment Market Attractiveness Index

6.5.1.    By Country

6.5.2.    By Drug Class

6.5.3.    By Sales Channel

7.    Latin America Opioid Dependence Treatment Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) Forecast, By Country

7.2.1.    Brazil Opioid Dependence Treatment Market

7.2.2.    Mexico Opioid Dependence Treatment Market

7.2.3.    Argentina Opioid Dependence Treatment Market

7.2.4.    Rest of Latin America Opioid Dependence Treatment Market

7.3.    Latin America Opioid Dependence Treatment Market, By Drug Class

7.3.1.    Buprenorphine

7.3.2.    Naloxone

7.3.3.    Methadone

7.4.    Latin America Opioid Dependence Treatment Market, By Sales Channel

7.4.1.    Retail Pharmacies

7.4.2.    Hospitals

7.4.3.    Rehabilitation Centres

7.5.    Latin America Opioid Dependence Treatment Market Attractiveness Index

7.5.1.    By Country

7.5.2.    By Drug Class

7.5.3.    By Sales Channel

8.    Europe Opioid Dependence Treatment Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    U.K. Opioid Dependence Treatment Market

8.2.2.    Germany Opioid Dependence Treatment Market

8.2.3.    Italy Opioid Dependence Treatment Market

8.2.4.    France Opioid Dependence Treatment Market

8.2.5.    Spain Opioid Dependence Treatment Market

8.2.6.    Russia Opioid Dependence Treatment Market

8.2.7.    Poland Opioid Dependence Treatment Market

8.2.8.    BENELUX Opioid Dependence Treatment Market

8.2.9.    NORDIC Opioid Dependence Treatment Market

8.2.10.    Rest of Europe Opioid Dependence Treatment Market

8.3.    Europe Opioid Dependence Treatment Market, By Drug Class

8.3.1.    Buprenorphine

8.3.2.    Naloxone

8.3.3.    Methadone

8.4.    Europe Opioid Dependence Treatment Market, By Sales Channel

8.4.1.    Retail Pharmacies

8.4.2.    Hospitals

8.4.3.    Rehabilitation Centres

8.5.    Europe Opioid Dependence Treatment Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Drug Class

8.5.3.    By Sales Channel

9.    Asia Pacific Opioid Dependence Treatment Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    China Opioid Dependence Treatment Market

9.2.2.    India Opioid Dependence Treatment Market

9.2.3.    Japan Opioid Dependence Treatment Market

9.2.4.    Australia and New Zealand Opioid Dependence Treatment Market

9.2.5.    South Korea Opioid Dependence Treatment Market

9.2.6.    ASEAN Opioid Dependence Treatment Market

9.2.7.    Rest of Asia Pacific Opioid Dependence Treatment Market

9.3.    Asia Pacific Opioid Dependence Treatment Market, By Drug Class

9.3.1.    Buprenorphine

9.3.2.    Naloxone

9.3.3.    Methadone

9.4.    Asia Pacific Opioid Dependence Treatment Market, By Sales Channel

9.4.1.    Retail Pharmacies

9.4.2.    Hospitals

9.4.3.    Rehabilitation Centres

9.5.    Asia Pacific Opioid Dependence Treatment Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Drug Class

9.5.3.    By Sales Channel

10.    Middle East Opioid Dependence Treatment Market, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    GCC Countries Opioid Dependence Treatment Market

10.2.2.    Israel Opioid Dependence Treatment Market

10.2.3.    Oman Opioid Dependence Treatment Market

10.2.4.    Rest of Middle East Opioid Dependence Treatment Market

10.3.    Middle East Opioid Dependence Treatment Market, By Drug Class

10.3.1.    Buprenorphine

10.3.2.    Naloxone

10.3.3.    Methadone

10.4.    Middle East Opioid Dependence Treatment Market, By Sales Channel

10.4.1.    Retail Pharmacies

10.4.2.    Hospitals

10.4.3.    Rehabilitation Centres

10.5.    Middle East Opioid Dependence Treatment Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Drug Class

10.5.3.    By Sales Channel

11.    Africa Opioid Dependence Treatment Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    South Africa Opioid Dependence Treatment Market

11.2.2.    Egypt Opioid Dependence Treatment Market

11.2.3.    North Africa Opioid Dependence Treatment Market

11.2.4.    Rest of Africa Opioid Dependence Treatment Market

11.3.    Africa Opioid Dependence Treatment Market, By Drug Class

11.3.1.    Buprenorphine

11.3.2.    Naloxone

11.3.3.    Methadone

11.4.    Africa Opioid Dependence Treatment Market, By Sales Channel

11.4.1.    Retail Pharmacies

11.4.2.    Hospitals

11.4.3.    Rehabilitation Centres

11.5.    Africa Opioid Dependence Treatment Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Drug Class

11.5.3.    By Sales Channel

12.    Recommendation

12.1.    Market Strategy

13.    Competitive Landscape

13.1.    Competition Dashboard

13.2.    List and Company Overview of Global Key Players

13.3.    Company Profiles

13.3.1.    Reckitt Benckiser Pharmaceuticals Inc.

13.3.1.1.    Company Overview

13.3.1.2.    Financial Overview

13.3.1.3.    Product Portfolio

13.3.1.4.    Key Developments

13.3.1.5.    Business Strategies

13.3.2.    Mylan

13.3.3.    Dr. Reddy's Laboratories

13.3.4.    ADAPT Pharma, Inc.

13.3.5.    LUMITOS AG

13.3.6.    Others

14.    Acronyms